Covered recipient · General Payments record
JENNIFER L REICHEL
Allopathic & Osteopathic Physicians Dermatology MOHS-Micrographic Surgery
General Payments · PY2019–2025
$5,292.16
- Reported across 111 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Honoraria | $2,000.00 | 1 |
| Food and Beverage | $346.80 | 14 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lumenis BE LTD | $2,000.00 | 1 |
| ABBVIE INC. | $112.30 | 4 |
| Regeneron Healthcare Solutions, Inc. | $57.77 | 2 |
| LEO Pharma Inc. | $54.44 | 2 |
| Janssen Biotech, Inc. | $28.10 | 1 |
| Amgen Inc. | $26.78 | 1 |
| ORGANOGENESIS INC. | $23.48 | 1 |
| REVANCE THERAPEUTICS, INC. | $19.55 | 1 |
| Lilly USA, LLC | $14.43 | 1 |
| Organon LLC | $9.95 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $31.11 | 02/20/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203819587 | CMS |
| ABBVIE INC. | $25.62 | 07/02/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203819593 | CMS |
| ABBVIE INC. | $34.40 | 08/20/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203819599 | CMS |
| ABBVIE INC. | $21.17 | 09/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203819605 | CMS |
| Amgen Inc. | $26.78 | 03/17/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228688026 | CMS |
| Janssen Biotech, Inc. | $28.10 | 07/16/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1175329498 | CMS |
| LEO Pharma Inc. | $24.82 | 09/23/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1252031180 | CMS |
| LEO Pharma Inc. | $29.62 | 11/13/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1252031182 | CMS |
| Lilly USA, LLC | $14.43 | 08/12/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186701887 | CMS |
| Lumenis BE LTD | $2,000.00 | 02/18/2025 | Honoraria | Undisputed | 06/30/2026 | 1185613374 | CMS |
| Organogenesis Inc. | $23.48 | 01/30/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1242033140 | CMS |
| Organon LLC | $9.95 | 03/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1237642230 | CMS |
| Regeneron Healthcare Solutions, Inc. | $28.93 | 05/01/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1213022695 | CMS |
| Regeneron Healthcare Solutions, Inc. | $28.84 | 07/24/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1213022697 | CMS |
| REVANCE THERAPEUTICS, INC. | $19.55 | 09/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1251171598 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024, 2025
- Source files
- Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.